肝细胞-话题@MedSci

#肝细胞#

513篇内容 | 2610人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2204334, encodeId=4d19220433468, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a> <a href='/topic/show?id=abde36296f5' target=_blank style='color:#2F92EE;'>#单细胞RNA测序#</a> <a href='/topic/show?id=07d0814257c' target=_blank style='color:#2F92EE;'>#肝脏再生#</a>, objectTitle=Nature：鉴定出一种负责修复受损肝脏组织的新型肝细胞, objectType=article, longId=825417, objectId=5c8682541e14, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240512/1715488649432_2185383.png, objectUrl=/article/show_article.do?id=5c8682541e14, replyNumber=0, likeNumber=1, createdTime=2024-05-12, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1863683, encodeId=d2c518636838c, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=人胚胎干细胞来源肝细胞成功治疗肝衰竭, objectType=article, longId=737155, objectId=d739e37155ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d739e37155ee, replyNumber=0, likeNumber=53, createdTime=2023-04-28, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d739e37155ee, moduleTitle=人胚胎干细胞来源肝细胞成功治疗肝衰竭, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d739e37155ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863677, encodeId=2e0018636e7d2, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Hepatology Communications：这几种饮食习惯与肝细胞癌息息相关！, objectType=article, longId=733260, objectId=6aa1e3326091, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6aa1e3326091, replyNumber=0, likeNumber=57, createdTime=2023-01-08, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6aa1e3326091, moduleTitle=Hepatology Communications：这几种饮食习惯与肝细胞癌息息相关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6aa1e3326091)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863685, encodeId=7b751863685d9, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Diabetes ：GIP和GLP-1增强磺脲类药物诱导肝细胞核因子1a突变携带者的胰岛素分泌, objectType=article, longId=738901, objectId=d917e38901bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d917e38901bd, replyNumber=0, likeNumber=49, createdTime=2022-12-12, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d917e38901bd, moduleTitle=Diabetes ：GIP和GLP-1增强磺脲类药物诱导肝细胞核因子1a突变携带者的胰岛素分泌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d917e38901bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863670, encodeId=363518636e0b6, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Cancers：肝细胞癌根治术后使用直接作用的抗病毒药物清除丙型肝炎病毒可以抑制癌症复发, objectType=article, longId=727864, objectId=1029e2786484, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1029e2786484, replyNumber=0, likeNumber=46, createdTime=2023-04-28, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1029e2786484, moduleTitle=Cancers：肝细胞癌根治术后使用直接作用的抗病毒药物清除丙型肝炎病毒可以抑制癌症复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1029e2786484)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863676, encodeId=075818636e6f8, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=European Radiology：混合型肝细胞胆管癌的LI-RADS M和LI-RADS 4/5风险分层, objectType=article, longId=732779, objectId=87bbe32779e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87bbe32779e7, replyNumber=0, likeNumber=63, createdTime=2023-01-09, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87bbe32779e7, moduleTitle=European Radiology：混合型肝细胞胆管癌的LI-RADS M和LI-RADS 4/5风险分层, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87bbe32779e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863674, encodeId=6ce118636e4a0, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=NEJM Evid：Tremelimumab联合Durvalumab用于不可切除肝细胞癌的治疗, objectType=article, longId=729494, objectId=1842e294948c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1842e294948c, replyNumber=0, likeNumber=52, createdTime=2022-10-02, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1842e294948c, moduleTitle=NEJM Evid：Tremelimumab联合Durvalumab用于不可切除肝细胞癌的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1842e294948c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863678, encodeId=c38d18636e8fd, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=HAEMOPHILIA：直接抗病毒药物时代血友病患者肝细胞癌的患病率和危险因素：一项全国住院患者样本研究, objectType=article, longId=734060, objectId=6f1fe3406031, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f1fe3406031, replyNumber=0, likeNumber=61, createdTime=2023-02-07, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f1fe3406031, moduleTitle=HAEMOPHILIA：直接抗病毒药物时代血友病患者肝细胞癌的患病率和危险因素：一项全国住院患者样本研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f1fe3406031)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863664, encodeId=1b63186366467, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Clin Cancer Res：Pembrolizumab单药治疗晚期肝细胞癌的效果, objectType=article, longId=724681, objectId=ae69e2468173, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae69e2468173, replyNumber=0, likeNumber=44, createdTime=2023-03-28, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae69e2468173, moduleTitle=Clin Cancer Res：Pembrolizumab单药治疗晚期肝细胞癌的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae69e2468173)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863662, encodeId=1c4d186366285, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=BMC Cancer：仑伐替尼联合PD-1抑制剂治疗晚期肝细胞癌的真实世界疗效, objectType=article, longId=301506, objectId=0b2e301506ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b2e301506ca, replyNumber=0, likeNumber=56, createdTime=2022-04-20, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b2e301506ca, moduleTitle=BMC Cancer：仑伐替尼联合PD-1抑制剂治疗晚期肝细胞癌的真实世界疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b2e301506ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863684, encodeId=54c51863684b3, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Cancer：丙型肝炎病毒感染和肝细胞癌患者持续病毒学应答与临床预后的关系, objectType=article, longId=737348, objectId=abbae37348fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abbae37348fc, replyNumber=0, likeNumber=45, createdTime=2023-02-03, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abbae37348fc, moduleTitle=Cancer：丙型肝炎病毒感染和肝细胞癌患者持续病毒学应答与临床预后的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abbae37348fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863681, encodeId=375a18636818a, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=人老肝不老！Cell子刊揭开人肝细胞更新的长期谜题！, objectType=article, longId=728669, objectId=9324e28669d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9324e28669d9, replyNumber=0, likeNumber=47, createdTime=2022-12-15, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9324e28669d9, moduleTitle=人老肝不老！Cell子刊揭开人肝细胞更新的长期谜题！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9324e28669d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863672, encodeId=0aca18636e2cc, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=ASCO 2022 | 肝细胞癌患者肝移植后 30 天再入院率的预测因素, objectType=article, longId=728445, objectId=f96ae28445fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f96ae28445fc, replyNumber=0, likeNumber=39, createdTime=2023-03-04, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f96ae28445fc, moduleTitle=ASCO 2022 | 肝细胞癌患者肝移植后 30 天再入院率的预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f96ae28445fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863666, encodeId=4026186366648, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Clin Cancer Res：甲胎蛋白可作为肝细胞癌采用Atezolizuma+贝伐单抗治疗的预后生物标志物, objectType=article, longId=726091, objectId=2391e260910b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2391e260910b, replyNumber=0, likeNumber=0, createdTime=2022-07-07, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2391e260910b, moduleTitle=Clin Cancer Res：甲胎蛋白可作为肝细胞癌采用Atezolizuma+贝伐单抗治疗的预后生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2391e260910b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863675, encodeId=a49018636e5c6, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=BMC Gastroenterology:术前纤维蛋白原/白蛋白比值可预测肝细胞癌肝切除术患者的预后, objectType=article, longId=732106, objectId=20e0e3210656, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20e0e3210656, replyNumber=0, likeNumber=50, createdTime=2022-12-12, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20e0e3210656, moduleTitle=BMC Gastroenterology:术前纤维蛋白原/白蛋白比值可预测肝细胞癌肝切除术患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20e0e3210656)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863641, encodeId=ff641863641b0, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=BMC Cancer：倾向评分匹配（PSM）研究表明抗PD-1联合索拉非尼较抗PD-1单药改善晚期肝细胞癌患者的预后, objectType=article, longId=294048, objectId=4fc429404878, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fc429404878, replyNumber=0, likeNumber=49, createdTime=2022-10-02, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fc429404878, moduleTitle=BMC Cancer：倾向评分匹配（PSM）研究表明抗PD-1联合索拉非尼较抗PD-1单药改善晚期肝细胞癌患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4fc429404878)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863656, encodeId=6adf186365624, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=STTT：治愈乙肝新希望：新型纳米载体，递送siRNA特异性靶向肝细胞, objectType=article, longId=299378, objectId=64612993e804, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64612993e804, replyNumber=0, likeNumber=47, createdTime=2022-12-23, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64612993e804, moduleTitle=STTT：治愈乙肝新希望：新型纳米载体，递送siRNA特异性靶向肝细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64612993e804)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863669, encodeId=788d186366934, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=BMC Cancer：BCLC B期肝细胞癌（HCC）患者初始使用仑伐替尼治疗的疗效, objectType=article, longId=726452, objectId=a4efe2645295, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4efe2645295, replyNumber=0, likeNumber=50, createdTime=2023-01-06, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4efe2645295, moduleTitle=BMC Cancer：BCLC B期肝细胞癌（HCC）患者初始使用仑伐替尼治疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4efe2645295)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863645, encodeId=331c186364526, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Front Oncol：PD-L1高表达是肝细胞癌患者手术切除后索拉非尼辅助治疗后复发的独立预测因素, objectType=article, longId=294335, objectId=1c8d29433575, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c8d29433575, replyNumber=0, likeNumber=48, createdTime=2022-01-31, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c8d29433575, moduleTitle=Front Oncol：PD-L1高表达是肝细胞癌患者手术切除后索拉非尼辅助治疗后复发的独立预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c8d29433575)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863642, encodeId=70581863642f3, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=European Radiology：混合性肝细胞癌-胆管癌的这些MRI表现提示了预后！, objectType=article, longId=294082, objectId=5b4c294082d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b4c294082d9, replyNumber=0, likeNumber=47, createdTime=2022-10-17, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b4c294082d9, moduleTitle=European Radiology：混合性肝细胞癌-胆管癌的这些MRI表现提示了预后！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b4c294082d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肝细胞

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#肝细胞# #单细胞RNA测序# #肝脏再生#

2024-05-12发表于上海

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

人胚胎干细胞来源肝细胞成功治疗肝衰竭

2023-04-28

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Hepatology Communications：这几种饮食习惯与肝细胞癌息息相关！

2023-01-08

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Diabetes ：GIP和GLP-1增强磺脲类药物诱导肝细胞核因子1a突变携带者的胰岛素分泌

2022-12-12

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Cancers：肝细胞癌根治术后使用直接作用的抗病毒药物清除丙型肝炎病毒可以抑制癌症复发

2023-04-28

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

European Radiology：混合型肝细胞胆管癌的LI-RADS M和LI-RADS 4/5风险分层

2023-01-09

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

NEJM Evid：Tremelimumab联合Durvalumab用于不可切除肝细胞癌的治疗

2022-10-02

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

HAEMOPHILIA：直接抗病毒药物时代血友病患者肝细胞癌的患病率和危险因素：一项全国住院患者样本研究

2023-02-07

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Clin Cancer Res：Pembrolizumab单药治疗晚期肝细胞癌的效果

2023-03-28

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

BMC Cancer：仑伐替尼联合PD-1抑制剂治疗晚期肝细胞癌的真实世界疗效

2022-04-20

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Cancer：丙型肝炎病毒感染和肝细胞癌患者持续病毒学应答与临床预后的关系

2023-02-03

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

人老肝不老！Cell子刊揭开人肝细胞更新的长期谜题！

2022-12-15

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

ASCO 2022 | 肝细胞癌患者肝移植后 30 天再入院率的预测因素

2023-03-04

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Clin Cancer Res：甲胎蛋白可作为肝细胞癌采用Atezolizuma+贝伐单抗治疗的预后生物标志物

2022-07-07

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

BMC Gastroenterology:术前纤维蛋白原/白蛋白比值可预测肝细胞癌肝切除术患者的预后

2022-12-12

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

BMC Cancer：倾向评分匹配（PSM）研究表明抗PD-1联合索拉非尼较抗PD-1单药改善晚期肝细胞癌患者的预后

2022-10-02

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

STTT：治愈乙肝新希望：新型纳米载体，递送siRNA特异性靶向肝细胞

2022-12-23

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

BMC Cancer：BCLC B期肝细胞癌（HCC）患者初始使用仑伐替尼治疗的疗效

2023-01-06

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Front Oncol：PD-L1高表达是肝细胞癌患者手术切除后索拉非尼辅助治疗后复发的独立预测因素

2022-01-31

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

European Radiology：混合性肝细胞癌-胆管癌的这些MRI表现提示了预后！

2022-10-17

科室
- - 订阅+
  - 更多科室
工具
服务